A previous study found that 10 cell proliferation genes, including BUB1, CCNB2, and CDK1, could act as indicators for response to immune checkpoint inhibitors in PD-L1 negative renal cell carcinoma [43]. The gene discussed is CCNB2; the disease is hereditary clear cell renal cell carcinoma.